Trial intelligence / Profile preview

Raltegravir in treatment-experienced HIV-1 infected Chinese patients

NCT01201239Phase 4Unknown

Start
Sep 2010
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1). Status: unknown.

02

Drugs

raltegravir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01201239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01201239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call